Cargando…
Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers
Gene fusions and MET exon skipping drive oncogenesis in 8–9% and 3% of non-small cell lung cancers (NSCLC) respectively. Their detection are essential for the management of patients since they confer sensitivity to specific targeted therapies with significant clinical benefit over conventional chemo...
Autores principales: | Gilson, Pauline, Pouget, Celso, Belmonte, Richard, Fadil, Smahane, Demange, Jessica, Rouyer, Marie, Lacour, Julien, Betz, Margaux, Dardare, Julie, Witz, Andréa, Merlin, Jean-Louis, Harlé, Alexandre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412571/ https://www.ncbi.nlm.nih.gov/pubmed/37558711 http://dx.doi.org/10.1038/s41598-023-39749-4 |
Ejemplares similares
-
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
por: Witz, Andréa, et al.
Publicado: (2023) -
ESR1 Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?
por: Betz, Margaux, et al.
Publicado: (2023) -
DDB2 represses epithelial-to-mesenchymal transition and sensitizes pancreatic ductal adenocarcinoma cells to chemotherapy
por: Dardare, Julie, et al.
Publicado: (2022) -
Efficient Lung Cancer Molecular Diagnostics by Combining Next Generation Sequencing with Reflex Idylla Genefusion Assay Testing
por: Nkosi, Dingani, et al.
Publicado: (2023) -
Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation
por: Leone, Alvaro, et al.
Publicado: (2022)